The ubiquitin–proteasome system in breast cancer
Authors:
Top Cited Papers
- 15 June 2023
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 29 (8) , 599-621
Abstract
No abstract availableKeywords
Funding Information
- National Ten Thousand Talent Program (W01020103)
- National Natural Science Foundation of China (82072912, 82171734)
- Natural Science Foundation of Shandong Province (ZR2021MH048)
- Taishan Scholar Foundation of Shandong Province (ts20190971)
- National Key Research and Development Program of China (2020YFA0712400)
This publication has 170 references indexed in Scilit:
- CDK‐mediated activation of the SCFFBXO28 ubiquitin ligase promotes MYC‐driven transcription and tumourigenesis and predicts poor survival in breast cancerEMBO Molecular Medicine, 2013
- Canonical Wnt signaling regulates Slug activity and links epithelial–mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repressionProceedings of the National Academy of Sciences, 2012
- RNF20 and USP44 Regulate Stem Cell Differentiation by Modulating H2B MonoubiquitylationMolecular Cell, 2012
- Vimentin in cancer and its potential as a molecular target for cancer therapyCellular and Molecular Life Sciences, 2011
- Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl HydroxylaseCancer Cell, 2009
- RAD6-Mediated Transcription-Coupled H2B Ubiquitylation Directly Stimulates H3K4 Methylation in Human CellsCell, 2009
- Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathwaysNature Reviews Molecular Cell Biology, 2009
- High cyclin B1 expression is associated with poor survival in breast cancerBritish Journal of Cancer, 2009
- Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1Oncogene, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008